Clinical Trial Update: Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting [NA]

View source ↗

Summary

A completed clinical trial evaluated whether stellate ganglion block affects the incidence of new atrial fibrillation after coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Stellate Ganglion Block

Snippet

Sponsor: Yangzhou University | Conditions: Stellate Ganglion Block | NA | Status: COMPLETED